Background and rationale for the proposed incentive program 2023/2026
Hørsholm, Denmark, 25 October 2023 - With reference to Notice of Extraordinary General Meeting in ExpreS2ion Biotech Holding AB (Press release as of Monday 23 October 2023) the board of directors hereby provides further details to the background and rationale for the proposed incentive program 2023/2026.In today's competitive business landscape, in which the demand for skilled scientists is very high, a small early-stage biotech company like ExpreS[2]ion needs to offer an alternative to the employment terms of larger corporations which can offer employee benefits such as job security and